Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Kodak Launches New Imaging Agent Product Line for Research Applications

Abstract:
Eastman Kodak Company's Molecular Imaging Systems group announced the introduction of KODAK X-SIGHT Imaging Agents, a novel line of imaging agents for in vivo molecular imaging applications.

Kodak Launches New Imaging Agent Product Line for Research Applications

NEW HAVEN, CT | Posted on February 13th, 2007

Once attached to a molecule and injected into an organism, the X-SIGHT imaging agents will travel to the target ( such as a tumor or plaque ) and illuminate the region of interest when excited by the appropriate wavelength of fluorescent light. X-SIGHT imaging agents are biocompatible and non-cytotoxic, making them safe and translatable for research studies in areas such as oncology, cardiology, diabetes, and inflammation, to name a few. They deliver not only superior brightness, but also enhanced photostability allowing more time for image capture.

This new product line leverages Kodak's 50 years of dye chemistry and nanotechnology expertise, merging world-class dyes with a state-of-the-art nanoparticle construct. X-SIGHT imaging agents are uniquely designed to offer biocompatibility along with superior brightness, providing researchers an incredibly bright and robust platform for safely locating their target of interest in vivo.

Together with Kodak's In-Vivo Imaging Systems, the X-SIGHT Imaging Agent line further expands the breadth of leading-edge solutions offered from Kodak to the research community.

"The launch of X-SIGHT Imaging Agents, is a significant milestone toward offering our customers a complete solution of systems and agents to advance their research," commented Shahram Hejazi, PhD, General Manager of Kodak's Molecular Imaging Systems division. "This introduction strengthens our leadership in the molecular imaging arena as we move forward to bridge the gap between preclinical and clinical applications."

X-SIGHT imaging agents can be readily conjugated to a wide range of targeting molecules, including peptides and antibodies, and their proprietary design can accommodate higher payloads of such targets while allowing for longer circulation time. Furthermore, X-SIGHT imaging agents are available in several distinct fluorescent wavelengths, enabling multi-fluorescent in vivo imaging. While the X-SIGHT imaging agents have been optimized for Kodak's In-Vivo Imaging Systems, they are also compatible with other commercially available systems.

X-SIGHT imaging agents are currently available for preclinical use in the United States and will be launched worldwide in March. Kodak further plans to introduce additional imaging agents throughout the year.

####

About Kodak’s Molecular Imaging Systems Group
Eastman Kodak Company’s Molecular Imaging Systems group - part of Kodak’s Health Group - develops and markets high performance digital imaging systems, imaging agents, film and accessories for the life science research and drug discovery/development market segments.

For more information, please click here

Contacts:
1-877-747-4357, express code 7.
Outside of the United States, call +1-203-786-5657.

Copyright © Eastman Kodak Company

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Products

Toronto-based Environmental Technology Pioneer Green Earth Nano Science Expands in EU February 6th, 2015

DELSEY by Philippe Starck DELSEY Launches New Collection by Philippe Starck February 4th, 2015

NEI introduces NANOMYTE® SuperAi, a Durable Anti-ice Coating December 4th, 2014

Biosenta Inc. Updates New Household Disinfectant Testing Results; It Kills 100% of a Broad Range of Deadly Molds, Fungi, Bacteria, and Viruses, Including Ebola and Enterovirus D68 November 20th, 2014

Nanomedicine

Graphene reduces wear of alumina ceramic March 26th, 2015

Application of Graphene Oxide in Body Implants in Iran March 26th, 2015

Nanorobotic agents open the blood-brain barrier, offering hope for new brain treatments March 25th, 2015

Nanotechnology in Medical Devices Market is expected to reach $8.5 Billion by 2019 March 25th, 2015

Announcements

Industrial Nanotech, Inc. Announces Next Large Order from the Oil and Gas Industry March 26th, 2015

Quantum compute this -- WSU mathematicians build code to take on toughest of cyber attacks: Revamped knapsack code offers online security for the future March 26th, 2015

Thousands of atoms entangled with a single photon: Result could make atomic clocks more accurate March 26th, 2015

Square ice filling for a graphene sandwich March 26th, 2015

Human Interest/Art

2015 Nanonics Image Contest January 29th, 2015

OCSiAl supports NanoART Imagery Contest January 23rd, 2015

EnvisioNano: An image contest hosted by the National Nanotechnology Initiative (NNI) January 22nd, 2015

Oxford Instruments Asylum Research Announces AFM Image Contest Winners January 11th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE